Clinical Trial

Food Limitations In Crohn's Disease and Ulcerative coliTis

Study acronym: FLIT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to increase the knowledge on what type of diet affects inflammation and how to better convay that information in patients with inflammatory bowel disease (IBD) and decrease selective eating in patients with IBD. The main questions it aims to answer are: * will the use of calprotectin as a control for changes in inflammation decrease selective food choices? * will the use of a digital information tool increase quality of life (QoL) och decrease selctive eating patterns? * will a diet based on nordic food choices decrease inflammation and increase QoL? Researchers will compare with IBD-patients in ordinary care. Participants will eat a test diet during six weeks or go through a digital information tool.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-04; most recent amendment 2026-05-27.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-05-27
Trial Details
NCT Number NCT07289672
Lead Sponsor Region Skane
Conditions Crohn Disease (CD), Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
Enrollment 140 participants
Start Date 2026-04-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-28